Riskpilot← Back to searchSign inGet full accessBack on Track AB
ABActiveOrg 5563189405Sofielundsgatan 5Wholesale of pharmaceutical and medical goods · NACE 4646Est. 198829 employees
Revenue 2025
SEK 57,5M
-10% vs 2024
EBITDA margin
10.0%
+148% vs 2024
Equity ratio
28.1%
Financial strength
Net profit 2025
SEK 737K
+688% vs 2024
| Revenue | SEK 57,5M | -10% |
| EBITDA | SEK 5,7M | +148% |
| Net profit | SEK 737K | +688% |
| Total assets | SEK 80,2M | +9% |
| Equity | SEK 22,5M | +4% |
| Employees | 29 | — |
Legal name
Back on Track AB
Org number
5563189405
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
8 februari 1988
Share capital
SEK 100 000
Employees
29 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Beselin, Erland Henrik Borgerud, Anna-Lena Gunnel Viveca Brinkeborn Beselin, Christopher B
Company purpose
Bolaget skall bedriva handel med konfektion och textiler, tillbehör för sjuk- och friskvård samt naturmedel, värdepappershandel, handel med konst och antikviteter, joint ventures tillsammans med svenska företag i Kina, import och export av konfektion och textilier mellan Asien och övriga världen, ävensom idka annan därmed förenlig verksamhet.
Address
Sofielundsgatan 5
Phone
+46321181313
Email
anna-lena.borgerud@backontrack.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 47 215 | 64 948 | 65 934 | 65 118 | 54 471 | 63 642 | 57 497 |
| Staff expenses | — | — | — | — | — | — | — | — | −19 509 | −14 419 |
| EBITDA | 1 397 | 2 637 | 2 617 | 3 875 | 3 580 | 1 330 | 4 893 | −2 150 | −11 996 | 5 735 |
| Depreciation & amort. | −423 | −434 | −477 | −440 | −453 | −437 | −759 | −1 264 | −2 157 | −1 606 |
| EBIT | 974 | 2 203 | 2 140 | 3 435 | 3 127 | 893 | 4 134 | −3 414 | −14 153 | 4 129 |
| Net financials | 678 | −791 | −1 081 | −4 845 | −52 | 2 909 | −2 379 | −26 955 | −1 591 | −723 |
| Profit before tax | 1 654 | 1 413 | 1 060 | 1 022 | 1 028 | 1 217 | 1 887 | −8 022 | 356 | 737 |
| Tax | −278 | −301 | −278 | −432 | −268 | −244 | −420 | −342 | −263 | — |
| Net profit | 1 376 | 1 112 | 782 | 590 | 760 | 973 | 1 467 | −8 364 | 94 | 737 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 46 309 | 55 143 | 68 532 | 39 719 | 46 186 | 38 111 | 58 613 | 114 633 | 73 427 | 80 161 |
| Equity | 16 345 | 17 456 | 18 238 | 18 827 | 19 587 | 20 560 | 22 027 | 13 663 | 21 757 | 22 544 |
| Long-term debt | 7 131 | 1 583 | 4 719 | 10 791 | 4 394 | 2 032 | 11 603 | 70 036 | 23 467 | 24 177 |
| Short-term debt | 22 833 | 36 104 | 45 575 | 10 100 | 22 204 | 15 519 | 24 983 | 30 933 | 28 203 | 33 440 |
| Total debt | 29 964 | 37 687 | 50 294 | 20 891 | 26 598 | 17 551 | 36 586 | 100 969 | 51 670 | 57 617 |
EBITDA margin
10.0%
This company
15.8%
Market median
-37% vs market
20152025
Equity ratio
28.1%
This company
38.2%
Market median
-26% vs market
20152025
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
20152025
Net profit margin
1.3%
This company
8.1%
Market median
-84% vs market
20152025
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20152025
Debt / equity
2.56×
This company
0.62×
Market median
-313% vs market
20152025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-01-01 – 2024-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
II Chief Auditor | Chief Auditor | 2022 | — | — |
JB Chief Auditor | Chief Auditor | 2023 | — | — |
EB Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
RP Audit | Audit | 2024 | — | — |
AG External Signatory | External Signatory | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Diomed Aktiebolag | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Diomed Aktiebolag
Back on Track AB Board members of Back on Track AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Isac Ilijas Dahlstedt | Chief Auditor | 0 companies |
| Joanna Benes | Chief Auditor | 0 companies |
| Erland Beselin | Chief Executive Officer | 0 companies |
| Rolf Patrik Spets | Audit | 0 companies |
| Anna-Lena Gunnel Viveca Borgerud | External Signatory | 0 companies |
| Christopher B Brinkeborn Beselin | Deputy Board Member | 0 companies |
| Eleonor Cecilia Brinkeborn Beselin | Deputy Board Member | 0 companies |